Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Adamo

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Organic Letters|December 31, 2010
First synthesis of C. difficile PS-II cell wall polysaccharide repeating unitElisa Danieli, Luigi Lay, Daniela Proietti, et al.
Chemical Science|April 21, 2015
Synthetically defined glycoprotein vaccines: current status and future directionsRoberto Adamo, Alberto Nilo, Bastien Castagner, et al.
Expert Review of Vaccines|September 3, 2019
Glycoconjugate vaccines: current approaches towards faster vaccine designFrancesca Micoli, Linda Del Bino, Renzo Alfini, et al.
Molecular Pharmaceutics|April 14, 2015
Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein AntigenAgnese Donadei, Simona Gallorini, Francesco Berti, et al.
Glycoconjugate Journal|June 5, 2010
Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugatesAnna Kabanova, Roberto Adamo, Daniela Proietti, et al.
Molecules (Basel, Switzerland)|August 22, 2018
Structure-Immunogenicity Relationship of α- and β-Tetrasaccharide Glycoforms from <i>Bacillus anthracis</i> Exosporium and Fragments ThereofRiccardo De Ricco, Christy L Ventura, Filippo Carboni, et al.
RSC Advances|May 6, 2022
Automated glycan assembly of <i>Streptococcus pneumoniae</i> type 14 capsular polysaccharide fragmentsJoão Louçano, Peter Both, Andrea Marchesi, et al.
Frontiers in Immunology|November 19, 2025
An mRNA-based FimH nanoparticle vaccine against uropathogenic <i>Escherichia coli</i> is highly immunogenic in rodentsSandro Roier, Roberto Adamo, Roberto Rosini, et al.
The Journal of Infectious Diseases|October 24, 2019
Evaluation of Immune Responses to Group B Streptococcus Type III Oligosaccharides Containing a Minimal Protective EpitopeFilippo Carboni, Francesca Angiolini, Monica Fabbrini, et al.
Chemical Reviews|May 24, 2022
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial ResistanceLinda Del Bino, Kitt Emilie Østerlid, Dung-Yeh Wu, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Organic Letters|December 31, 2010
First synthesis of C. difficile PS-II cell wall polysaccharide repeating unitElisa Danieli, Luigi Lay, Daniela Proietti, et al.
Chemical Science|April 21, 2015
Synthetically defined glycoprotein vaccines: current status and future directionsRoberto Adamo, Alberto Nilo, Bastien Castagner, et al.
Expert Review of Vaccines|September 3, 2019
Glycoconjugate vaccines: current approaches towards faster vaccine designFrancesca Micoli, Linda Del Bino, Renzo Alfini, et al.
Molecular Pharmaceutics|April 14, 2015
Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein AntigenAgnese Donadei, Simona Gallorini, Francesco Berti, et al.
Glycoconjugate Journal|June 5, 2010
Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugatesAnna Kabanova, Roberto Adamo, Daniela Proietti, et al.
Molecules (Basel, Switzerland)|August 22, 2018
Structure-Immunogenicity Relationship of α- and β-Tetrasaccharide Glycoforms from <i>Bacillus anthracis</i> Exosporium and Fragments ThereofRiccardo De Ricco, Christy L Ventura, Filippo Carboni, et al.
RSC Advances|May 6, 2022
Automated glycan assembly of <i>Streptococcus pneumoniae</i> type 14 capsular polysaccharide fragmentsJoão Louçano, Peter Both, Andrea Marchesi, et al.
Frontiers in Immunology|November 19, 2025
An mRNA-based FimH nanoparticle vaccine against uropathogenic <i>Escherichia coli</i> is highly immunogenic in rodentsSandro Roier, Roberto Adamo, Roberto Rosini, et al.
The Journal of Infectious Diseases|October 24, 2019
Evaluation of Immune Responses to Group B Streptococcus Type III Oligosaccharides Containing a Minimal Protective EpitopeFilippo Carboni, Francesca Angiolini, Monica Fabbrini, et al.
Chemical Reviews|May 24, 2022
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial ResistanceLinda Del Bino, Kitt Emilie Østerlid, Dung-Yeh Wu, et al.
Pageof 10